Pleomorphic lobular carcinoma

Radhi, J. M. 2000. Immunohistochemical analysis of pleomorphic lobular carcinoma Higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 36 156-160. 

Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast an aggressive tumor showing apocrine differentiation. Hum Pathol. 1992 23 655-662. 

Bassler R, Kronsbein H. Disseminated lobular carcinoma—a predominantly pleomorphic lobular carcinoma of the whole breast. Pathol Res Pract. 1980 166 456-470. 

Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast Role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005 207 1-13. 

Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast Clinicopathologic feamres of 12 cases. Mod Pathol. 1998 11 814-822. 

Frolik D, Caduff R, Varga Z. Pleomorphic lobular carcinoma of the breast Its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology. 2001 39 503-513. 

Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma Morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000 24 1650-1656. 

Dabbs DJ, Kaplai M, Chivukula M, et al. The spectrum of mor-phomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immuno-histochem Mol Morphol. 2007 15 260-266. 

Simpson PT, Reis-Filho JS, Lambros MB, et al. Molecular profiling pleomorphic lobular carcinomas of the breast Evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol. 2008 215 231-244. 

Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast A report of 24 cases. Mod Pathol. 2002 15 1044-1050. 

---